A Low-Frequency Variant in MAPK14 Provides Mechanistic Evidence of a Link With Myeloperoxidase: A Prognostic Cardiovascular Risk Marker

Journal of the American Heart Association - United Kingdom
doi 10.1161/jaha.114.001074

Related search